Q3 2023 Holdings
Filed 2023-10-03 | 8 holdings | $64.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Centessa Pharmaceuticals plc(CNTA) | Ordinary Shares | 152309100 | $25.4M | 3,931,818 | 39.4% |
| Dyne Therapeutics, Inc.(DYN) | Common Stock | 26818M108 | $19.9M | 2,220,034 | 30.8% |
| Allogene Therapeutics, Inc.(ALLO) | Common Stock | 019770106 | $5.7M | 1,798,163 | 8.8% |
| Kronos Bio, Inc.(KRON1USD) | Common Stock | 50107A104 | $3.6M | 2,765,314 | 5.6% |
| LianBio | Ordinary Shares | 53000N108 | $3.4M | 2,282,084 | 5.3% |
| Kinnate Biopharma, Inc. | Common Stock | 49705R105 | $3.1M | 2,207,772 | 4.8% |
| Praxis Precision Medicines, Inc. | Common Stock | 74006W108 | $2.5M | 1,469,665 | 3.9% |
| Ikena Oncology, Inc. | Common Stock | 45175G108 | $975.1K | 225,192 | 1.5% |